ATE187640T1 - Arzneimittel in tablettenform mit verzögerter wirkstoffabgabe auf basis von hochmolekularen polysaccharidgranulaten - Google Patents

Arzneimittel in tablettenform mit verzögerter wirkstoffabgabe auf basis von hochmolekularen polysaccharidgranulaten

Info

Publication number
ATE187640T1
ATE187640T1 AT96901859T AT96901859T ATE187640T1 AT E187640 T1 ATE187640 T1 AT E187640T1 AT 96901859 T AT96901859 T AT 96901859T AT 96901859 T AT96901859 T AT 96901859T AT E187640 T1 ATE187640 T1 AT E187640T1
Authority
AT
Austria
Prior art keywords
high molecular
delayed release
tablet form
medicinal product
release based
Prior art date
Application number
AT96901859T
Other languages
English (en)
Inventor
Jean-Pierre Collaueri
Guillaume Conrath
Paul-Joel Derian
Gabriel Gousset
Frederic Mauger
Original Assignee
Rhodia Chimie Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhodia Chimie Sa filed Critical Rhodia Chimie Sa
Application granted granted Critical
Publication of ATE187640T1 publication Critical patent/ATE187640T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT96901859T 1995-01-27 1996-01-26 Arzneimittel in tablettenform mit verzögerter wirkstoffabgabe auf basis von hochmolekularen polysaccharidgranulaten ATE187640T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9500946A FR2729857B1 (fr) 1995-01-27 1995-01-27 Compositions pharmaceutiques sous forme de comprimes a liberation prolongee a base de granules en polysaccharides de haut poids moleculaire
PCT/FR1996/000133 WO1996022767A1 (fr) 1995-01-27 1996-01-26 Compositions pharmaceutiques sous forme de comprimes a liberation prolongee a base de granules en polysaccharides de haut poids moleculaire

Publications (1)

Publication Number Publication Date
ATE187640T1 true ATE187640T1 (de) 2000-01-15

Family

ID=9475564

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96901859T ATE187640T1 (de) 1995-01-27 1996-01-26 Arzneimittel in tablettenform mit verzögerter wirkstoffabgabe auf basis von hochmolekularen polysaccharidgranulaten

Country Status (10)

Country Link
US (1) US6221393B1 (de)
EP (1) EP0805676B1 (de)
JP (1) JPH10512873A (de)
AT (1) ATE187640T1 (de)
AU (1) AU4627096A (de)
CA (1) CA2210321C (de)
DE (1) DE69605649T2 (de)
ES (1) ES2143180T3 (de)
FR (1) FR2729857B1 (de)
WO (1) WO1996022767A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
IN186245B (de) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
FR2785191B1 (fr) * 1998-11-02 2002-05-31 Rhodia Chimie Sa Utilisation de gommes xanthanes pour la preparation de compositions pharmaceutiques
EP1404333A1 (de) * 2001-07-06 2004-04-07 Endo Pharmaceuticals Inc. Kontrolliert freisetzende formulierungen von oxymorphon
WO2003004033A1 (en) * 2001-07-06 2003-01-16 Penwest Pharmaceuticals Company Sustained release formulations of oxymorphone
CA2459976A1 (en) * 2001-09-26 2003-04-03 Penwest Pharmaceuticals Company Opioid formulations having reduced potential for abuse
WO2004026256A2 (en) * 2002-09-20 2004-04-01 Alpharma, Inc. Sustained-release opioid formulations and methods of use
BRPI0408805A (pt) * 2003-03-31 2006-03-28 Pliva Lachema As composição farmacêutica contendo complexo de platina e método de fabricação da mesma
US20050042289A1 (en) * 2003-04-29 2005-02-24 Yamanouchi Pharma Technologies, Inc. Tablets and methods for modified release of hydrophylic and other active agents
WO2005005484A1 (ja) 2003-07-11 2005-01-20 Asahi Kasei Chemicals Corporation 機能性澱粉粉末
US7999003B2 (en) * 2003-08-26 2011-08-16 Mannatech, Incorporated Antioxidant compositions and methods thereto
EP1909770B1 (de) * 2005-02-22 2013-03-20 Sun Pharmaceutical Industries Limited Kontrolliert freigesetzte, orale zusammensetzung mit levetiracetam
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
US20070212414A1 (en) * 2006-03-08 2007-09-13 Penwest Pharmaceuticals Co. Ethanol-resistant sustained release formulations
US8987438B2 (en) * 2006-07-20 2015-03-24 Rhodia Operations Method for making derivatized guar gum and derivatized guar gum made thereby
US20080085304A1 (en) * 2006-10-10 2008-04-10 Penwest Pharmaceuticals Co. Robust sustained release formulations
CA2652981C (en) * 2006-10-10 2012-05-01 Penwest Pharmaceuticals Co. Robust sustained release formulations
AU2011252040C1 (en) 2010-05-10 2015-04-02 Euro-Celtique S.A. Manufacturing of active-free granules and tablets comprising the same
FR3020571B1 (fr) 2014-05-05 2017-08-25 Soc D'exploitation De Produits Pour Les Ind Chimiques Seppic Co-granules de gomme de xanthane et de gomme d'acacia

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8515484D0 (en) * 1985-06-19 1985-07-24 Shell Int Research Heteropolysaccharide particles
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
IT1191674B (it) * 1986-03-07 1988-03-23 Eurand Spa Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale
FR2600267A1 (fr) * 1986-06-19 1987-12-24 Rhone Poulenc Chimie Granules de biopolymere a dispersabilite et dissolution rapides
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
US5077051A (en) * 1990-04-10 1991-12-31 Warner-Lambert Company Sustained release of active agents from bioadhesive microcapsules
EP0676967A4 (de) * 1992-12-30 1996-10-02 Fmc Corp Leicht verfügbarer hilfsstoff zur verzögerten freisetzung auf der basis von konjac glukomannan.
US5662933A (en) * 1993-09-09 1997-09-02 Edward Mendell Co., Inc. Controlled release formulation (albuterol)
US5871776A (en) * 1995-01-31 1999-02-16 Mehta; Atul M. Controlled-release nifedipine

Also Published As

Publication number Publication date
MX9705611A (es) 1997-10-31
AU4627096A (en) 1996-08-14
DE69605649T2 (de) 2000-06-21
CA2210321A1 (fr) 1996-08-01
FR2729857A1 (fr) 1996-08-02
US6221393B1 (en) 2001-04-24
EP0805676A1 (de) 1997-11-12
WO1996022767A1 (fr) 1996-08-01
CA2210321C (fr) 2003-03-18
FR2729857B1 (fr) 1997-04-04
ES2143180T3 (es) 2000-05-01
EP0805676B1 (de) 1999-12-15
DE69605649D1 (de) 2000-01-20
JPH10512873A (ja) 1998-12-08

Similar Documents

Publication Publication Date Title
ATE187640T1 (de) Arzneimittel in tablettenform mit verzögerter wirkstoffabgabe auf basis von hochmolekularen polysaccharidgranulaten
ECSP941148A (es) Medicamento en forma de comprimido con liberacion retardada de substancia activa
FI973419A0 (fi) Epäorgaanisten aerogeelien käyttö lääkkeiden valmistuksessa
NO20001042D0 (no) Oftalmiske preparater med forsinket frigivelse inneholdende vannoppløselige medikamenter
DE69940557D1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
DE69620606D1 (de) Feste oral anzuwendende arzeneiform
BR9917012A (pt) Comprimido matricial, permitindo a liberação prolongada de gliclazida, após administração por via oral
NO953767L (no) Tverrbundet amylose som et binde-/opplösende middel i tabletter
GB1204580A (en) Pharmaceutical dosage forms
CZ15295A3 (en) Solid pharmaceutical dosing unit
KR920019365A (ko) 디리트로마이신을 함유하는 약학 제형
KR920000330A (ko) 백합과 알로에속에 속하는 식물의 진공 동결 건조체와 이를 이용한 정제(錠劑) 제품 및 그 제조방법
HUP9901021A2 (hu) Famciklovirt nagy koncentrációban tartalmazó gyógyászati tabletták
GR3018795T3 (en) Emulsion-free emulsion polymers in sustained-release pharmaceutical compositions and their production
KR950007852A (ko) 우라실을 유효성분으로 함유하는 관절염 치료제
UA22792A (uk) Гомеопатичний лікарський засіб " фарингол - arn "
KR950002772A (ko) 한방변비치료제
ATE14837T1 (de) Pharmazeutische zusammensetzungen.
KR960033451A (ko) 나트륨 치환 트립토판을 포함하는 b형 간염 치료제
UA10109A (uk) Дитячий лікарський засіб "валькофен", який має жарознижуючу, анальгетичну та протизапальну активність
UA29946A (uk) Ентеросорбент "фібросорб віта"

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties